podcast with Tim Boreham
Melbourne, Oct 18, 2019 AEST (ABN Newswire) - Anatara Lifesciences (
ASX:ANR) CEO Steve Lydeamore sat down with Tim Boreham this week for Stockhead's new podcast series, "The Health Kick".
Anatara Lifesciences: Standing out in the gut health market, solving scours in livestock and the future of antibiotics in the food chain
In the interview, Steve discusses:
- Anatara's journey to today and its dual opportunities in human and animal gut health
- The significant unmet need for complementary medicines in the treatment of irritable bowel syndrome and inflammatory bowel disease
- How Anatara's Gastrointestinal ReProgramming (GaRP) dietary supplement unique approach addresses all three significant factors in chronic bowel conditions - microbiome dysbiosis, inflammation and mucosal damage
- Recent successful completion of GaRP's preclinical program, with statistically significant efficacy data from its in vivo animal studies and further positive in vitro proof of concept data
- The upcoming human clinical trial for GaRP and in parallel, the preparation of a licencing package to approach potential partner companies in 2020
- The next step's for partnering the Company's anti-diarrhoeal product, Detach(r), in global markets and other livestock species
- Antimicrobial resistance is one of the greatest threats to mankind and how Detach(r) will help reduce in the use of antibiotics in livestock
Listen to the podcast interview please visit:
https://www.abnnewswire.net/lnk/HT7L087J
About Anatara Lifesciences Limited
Anatara Lifesciences Limited (ASX:ANR) is developing and commercialising innovative, evidence-based products for gastrointestinal health where there is significant unmet need. Anatara is a life sciences company with expertise in developing productsfor human and animal health. Anatara is focused on building a pipeline of human gastrointestinal health products. Underlying this product development program is our commitment to delivering real outcomes for patients and strong value for our shareholders.
| ||
|
